{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:22:06Z","timestamp":1784604126509,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/bjc.2011.236","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T20:07:48Z","timestamp":1309896468000},"page":"337-339","source":"Crossref","is-referenced-by-count":104,"title":["Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study"],"prefix":"10.1038","volume":"105","author":[{"given":"I","family":"Wikstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wilander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,5]]},"reference":[{"key":"BFbjc2011236_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djn099","volume":"100","author":"B Andrae","year":"2008","unstructured":"Andrae B, Kemetli L, Spar\u00e9n P, Silfverdal L, Strander B, Ryd W, Dillner J, T\u00f6rnberg S (2008) Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100: 605\u2013606","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011236_CR2","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/ijc.22114","volume":"119","author":"A Bos","year":"2006","unstructured":"Bos A, Rebolj M, Habbema JD, van Ballegooijen M (2006) Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 119: 2372\u20132375","journal-title":"Int J Cancer"},{"key":"BFbjc2011236_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/1055-9965.346.13.3","volume":"13","author":"S Eaker","year":"2004","unstructured":"Eaker S, Adami HO, Granath F, Wilander E, Spar\u00e9n P (2004) A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 13: 346\u2013354","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbjc2011236_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ijc.2910630610","volume":"63","author":"L Gustafsson","year":"1995","unstructured":"Gustafsson L, Spar\u00e9n P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, Adami HO (1995) Low efficiency of cytological screening for cancer in situ of the cervix in older women. Int J Cancer 63: 804\u2013809","journal-title":"Int J Cancer"},{"key":"BFbjc2011236_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1470-2045(10)70064-4","volume":"11","author":"U Gyllensten","year":"2010","unstructured":"Gyllensten U, Lindell M, Gustafsson I, Wilander E (2010) HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 11: 509\u2013510","journal-title":"Lancet Oncol"},{"key":"BFbjc2011236_CR6","doi-asserted-by":"publisher","first-page":"c1040","DOI":"10.1136\/bmj.c1040","volume":"340","author":"M G\u00f6k","year":"2010","unstructured":"G\u00f6k M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Beli\u00ebn JA, Babovic M, Snijders PJ, Meijer CJ (2010) HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340: c1040","journal-title":"BMJ"},{"key":"BFbjc2011236_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejogrb.2006.12.005","volume":"137","author":"PG Lindqvist","year":"2008","unstructured":"Lindqvist PG, Hellsten C, Rippe A (2008) Screening history of women in Malm\u00f6 with invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 137: 77\u201383","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BFbjc2011236_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"CJ Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DA, Snijders PJ (2009) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124: 516\u2013520","journal-title":"Int J Cancer"},{"key":"BFbjc2011236_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/01674820701504619","volume":"29","author":"MG Oscarsson","year":"2008","unstructured":"Oscarsson MG, Benzein EG, Wijma BE (2008) Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol 29: 23\u201331","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"BFbjc2011236_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J, New Technologies for Cervical Cancer screening (NTCC) Working Group (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasis: a randomised controlled trial. Lancet Oncol 11: 249\u2013257","journal-title":"Lancet Oncol"},{"key":"BFbjc2011236_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bjc.6605194","volume":"101","author":"K Sanner","year":"2009","unstructured":"Sanner K, Wikstr\u00f6m I, Strand A, Lindell M, Wilander E (2009) Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 101: 871\u2013874","journal-title":"Br J Cancer"},{"key":"BFbjc2011236_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2340\/00015555-0123","volume":"86","author":"H Stenvall","year":"2006","unstructured":"Stenvall H, Wikstr\u00f6m I, Wilander E (2006) Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device. Acta Derm Venereol 86: 465\u2013467","journal-title":"Acta Derm Venereol"},{"key":"BFbjc2011236_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/00016340701303747","volume":"86","author":"I Wikstr\u00f6m","year":"2007","unstructured":"Wikstr\u00f6m I, Stenvall H, Wilander E (2007a) Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand 86: 720\u2013725","journal-title":"Acta Obstet Gynecol Scand"},{"key":"BFbjc2011236_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2340\/00015555-0326","volume":"87","author":"I Wikstr\u00f6m","year":"2007","unstructured":"Wikstr\u00f6m I, Stenvall H, Wilander E (2007b) Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study. Acta Derm Venereol 87: 554\u2013555","journal-title":"Acta Derm Venereol"},{"key":"BFbjc2011236_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","volume":"103","author":"TC Wright Jr","year":"2004","unstructured":"Wright Jr TC, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, Noller KL, Roach N, Runowicz C, Saslow D (2004) Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103: 304\u2013309. Review","journal-title":"Obstet Gynecol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011236","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:37:53Z","timestamp":1686184673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFbjc2011236"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.236","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}